FdaApplication
NDA 008248
Identifiers
- fda_app_no: NDA008248
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP ANESTHESIA CRITICAL CARE |
| application_type | NDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WYAMINE SULFATE | MEPHENTERMINE SULFATE | EQ 30MG BASE/ML | INJECTABLE;INJECTION |
| WYAMINE SULFATE | MEPHENTERMINE SULFATE | EQ 15MG BASE/ML | INJECTABLE;INJECTION |
2 products